# Exenatide and Brown Adipose Tissue

> **NCT03002675** · PHASE4 · UNKNOWN · sponsor: **Ingrid Jazet** · enrollment: 24 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Bydureon

## Key facts

- **NCT ID:** NCT03002675
- **Lead sponsor:** Ingrid Jazet
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-06
- **Final completion:** —
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2016-12-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03002675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03002675, "Exenatide and Brown Adipose Tissue". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03002675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*